Alcon ALC

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.91 (+0.99%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Alcon (ALC)
    Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $93.03

    • Market Cap

      $46.01 Billion

    • Price-Earnings Ratio

      -53.47

    • Total Outstanding Shares

      494.62 Million Shares

    • Total Employees

      25,599

    • Dividend

      $0.24 Per Share Annually

    • IPO Date

      April 9, 2019

    • Primary Exchange

      New York Stock Exchange

    • Type

      Common Stock

    • Homepage

      https://www.alcon.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    April 1, 2012 to March 31, 2013
    MetricValue
    Net Cash Flow From Financing Activities$96.67 Million
    Net Cash Flow From Investing Activities, Continuing$-73.27 Million
    Net Cash Flow$4.16 Million
    Net Cash Flow, Continuing$4.16 Million
    Net Cash Flow From Operating Activities, Continuing$-19.24 Million
    Net Cash Flow From Financing Activities, Continuing$96.67 Million

    Income Statement

    April 1, 2012 to March 31, 2013
    MetricValue
    Diluted Earnings Per Share$-1.74
    Income/Loss From Continuing Operations Before Tax$-64.18 Million
    Income Tax Expense/Benefit, Deferred$-16.12 Million
    Diluted Average Shares$68.91 Million
    Net Income/Loss Attributable To Parent$-39.99 Million
    Preferred Stock Dividends And Other Adjustments$0

    Comprehensive Income

    April 1, 2012 to March 31, 2013
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$-39.86 Million
    Comprehensive Income/Loss$-39.99 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Other Comprehensive Income/Loss$-8.21 Million

    Balance Sheet

    April 1, 2012 to March 31, 2013
    MetricValue
    Accounts Payable$8.03 Million
    Long-term Debt$184.22 Million
    Current Assets$33.24 Million
    Assets$509.22 Million
    Equity$269.67 Million
    Liabilities$239.56 Million

    Historical Dividends

    Current dividend: $0.24 Per Share Annually
    Announcement DatePayment DateRecord DateAmountFrequency
    Feb 28, 2024May 16, 2024May 15, 2024$0.24Annually
    Mar 2, 2023May 12, 2023May 11, 2023$0.21Annually
    Feb 27, 2022May 5, 2022May 4, 2022$0.2Annually
    Feb 24, 2021May 6, 2021May 5, 2021$0.1Annually

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ALC from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.